A carregar...
Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access
INTRODUCTION: Access to pimavanserin, the only Parkinson disease–related psychosis treatment approved by the FDA, is restricted by insurance requirements, a limited distribution network, and high costs. Following initiation, patients require monitoring for safety and effectiveness. The primary objec...
Na minha lista:
| Publicado no: | Ment Health Clin |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
College of Psychiatric & Neurologic Pharmacists
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120983/ https://ncbi.nlm.nih.gov/pubmed/34026394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2021.05.187 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|